Bio-Path Holdings, Inc.
BPTH- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001133818
No open-market purchases or sales by Bio-Path Holdings, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Bio-Path Holdings, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 18 | 23 | +5 |
| Shares | 456.9K | 694.3K | +237.5K (+52.0%) |
| Value | $812.0K | $256.6K | −$555.4K (−68.4%) |
New holders (7)
Institutions that held Bio-Path Holdings, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Walleye Capital LLC | 209,238 | $77.4K | 0.00% |
| Strategic Advocates LLC | 35,119 | $13.0K | 0.01% |
| Warberg Asset Management LLC | 24,000 | $8.88K | 0.00% |
| Millennium Management LLC | 18,571 | $6.87K | 0.00% |
| HRT Financial LP | 17,923 | $6.00K | 0.00% |
| XTX Topco Ltd | 15,022 | $5.56K | 0.00% |
| McClarren Financial Advisors, Inc. | 1 | $0 | 0.00% |
Sold out (2)
Institutions that held Bio-Path Holdings, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Mount Yale Investment Advisors, LLC | 25,350 | $45.1K |
| Virtu Financial LLC | 11,912 | $21.0K |